ForSight VISION5, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://forsightvision5.com
Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2019-02-25
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT02742649
- Locations
- 🇵🇦
Clinica de Ojos Orillac - Calvo, Panama City, Panama
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
- Conditions
- Primary Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2015-09-01
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 81
- Registration Number
- NCT02537015
- Locations
- 🇺🇸
Vold Vision, Fayetteville, Arkansas, United States
🇺🇸Sall Medical Research Center, Artesia, California, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
Bimatoprost Ocular Insert Pharmacokinetic Study
- Conditions
- Healthy Volunteers
- Interventions
- Drug: 13mg Bimatoprost Ocular Insert
- First Posted Date
- 2015-05-14
- Last Posted Date
- 2015-05-14
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT02444767
- Locations
- 🇺🇸
Sall Medical Research Center, Artesia, California, United States
Survey of Patients Taking IOP-Lowering Eye Drops
- Conditions
- GlaucomaOcular Hypertension
- First Posted Date
- 2015-03-10
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT02384772
- Locations
- 🇺🇸
ForSight VISION5 Recruitment Referral Center, Menlo Park, California, United States
Dose-Ranging Study of the Bimatoprost Ocular Insert
- Conditions
- Primary Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2015-02-09
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- ForSight Vision5, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT02358369
- Locations
- 🇺🇸
Vold Vision, Fayetteville, Arkansas, United States
🇺🇸Sall Medical Research Center, Artesia, California, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
- Prev
- 1
- 2
- Next